Allscripts-Misys Healthcare (MDRX) Reports In-Line Q4 EPS; Issues FY12 EPS, Revs Outlook
Tweet
Share
E-mailGet Alerts MDRX Hot Sheet
Join SI Premium – FREE
Allscripts-Misys Healthcare (NASDAQ: MDRX) reported Q4 EPS of $0.25, in-line with the analyst estimate of $0.25. Revenue for the quarter came in at $388.2 million versus the consensus estimate of $379.03 million.
Allscripts-Misys Healthcare sees FY2012 EPS of $1.06-$1.10, versus the consensus of $1.10. Allscripts-Misys Healthcare sees FY2012 revenue of $1.62-$1.65 million, versus the consensus of $1.62 million.
For earnings history and earnings-related data on Allscripts-Misys Healthcare (MDRX) click here.
Allscripts-Misys Healthcare sees FY2012 EPS of $1.06-$1.10, versus the consensus of $1.10. Allscripts-Misys Healthcare sees FY2012 revenue of $1.62-$1.65 million, versus the consensus of $1.62 million.
For earnings history and earnings-related data on Allscripts-Misys Healthcare (MDRX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- SanDisk and Micron surge as Apple confirms memory price pass-through
- FedEx (FDX) PT Lowered to $424 at Bernstein SocGen Group
- SpaceX receives Baa1 rating from Moody's with stable outlook
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
